HR Bio Holdings Limited is a joint venture between Jiangsu Hengrui Medicine Co. Ltd. and an undisclosed investment firm. Jiangsu Hengrui Medicine Co. Ltd. is the largest ethical pharmaceutical company in China, specializing in multiple therapeutic areas such as oncology, endocrinology, cardiovascular and metabolic disorders, surgical products, and imaging agents. It is publicly traded on the Shanghai Security Exchange (Code: 600276).
Focus Areas
Notable Investments
